Recombinant human growth hormone (rhGH) therapy is widely used for short stature due to various causes, such as chromosomal/genetic abnormalities, small for gestational age (SGA), idiopathic short stature (ISS), and idiopathic GH deficiency (IGHD) [1]. This evidence concerns the gene GH1 and isolated congenital growth hormone deficiency.